Related Experiment Video
Updated: Sep 14, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Sporadic Apolipoprotein A-II Amyloidosis With Familial Renal Failure: A Mutation-Negative Case and Comprehensive
Liping Lin1, Hongyu Qiu2, Yanhua You1
1Department of Nephrology, West China Xiamen Hospital of Sichuan University, Xiamen, China.
Abstract:
We report a 32-year-old man who presented with proteinuria and a family history of renal failure. A renal biopsy revealed amyloid deposit in the glomeruli, renal interstitium, and arterioles. An abdominal fat aspirate was also positive for amyloid deposition. Following comprehensive evaluation, both acquired monoclonal immunoglobulin light chain amyloidosis (AL-type) and reactive amyloid A amyloidosis (AA-type) were excluded. Mass spectrometry analysis of the renal amyloid material indicated the presence of apolipoprotein A-II (ApoAII) amyloidosis. However, genetic sequencing did not identify any mutation in the coding sequence of ApoA-II. We discuss the rarity, aetiology, diagnosis, and management of apolipoprotein A-II amyloidosis.
Insights
A rare case of apolipoprotein A-II (ApoAII) amyloidosis was diagnosed in a man with kidney failure. This diagnosis was confirmed via mass spectrometry, excluding other common amyloid types.
Area of Science:
- Nephrology
- Genetics
- Biochemistry
Background:
- Amyloidosis is a group of diseases characterized by protein misfolding and deposition in organs.
- Renal involvement is common in amyloidosis, leading to progressive kidney failure.
- Apolipoprotein A-II (ApoAII) amyloidosis is an exceptionally rare form, often presenting with nephropathy.
Purpose of the Study:
- To report a unique case of apolipoprotein A-II amyloidosis.
- To highlight the diagnostic challenges and methods for rare amyloidosis subtypes.
- To discuss the current understanding of ApoAII amyloidosis etiology and management.
Main Methods:
- Renal biopsy and abdominal fat aspirate for amyloid detection.
- Exclusion of common amyloidosis types (AL and AA) through comprehensive evaluation.
- Mass spectrometry analysis of renal amyloid deposits to identify the specific protein.
- Genetic sequencing of the apolipoprotein A-II gene.
Main Results:
- Renal biopsy confirmed amyloid deposition in glomeruli, interstitium, and arterioles.
- Mass spectrometry identified apolipoprotein A-II as the deposited protein.
- Genetic sequencing revealed no mutations in the coding sequence of ApoA-II.
- Acquired monoclonal immunoglobulin light chain amyloidosis (AL-type) and reactive amyloid A amyloidosis (AA-type) were ruled out.
Conclusions:
- Apolipoprotein A-II amyloidosis is a rare cause of nephropathy.
- Diagnosis requires advanced techniques like mass spectrometry when common types are excluded.
- The genetic basis of this rare amyloidosis subtype remains to be fully elucidated.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Lysosomal Hydrolases
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

